Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[BMS-986278]1件: BMS-986278 (BMS-986278)1件: Admilparant 💬 1件: LPAR1 💬 8件: Gap junction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Regulation of actin cytoskeleton 💬1件: 85 💬
2BMS-9862781件: BMS-986278 (BMS-986278)1件: Admilparant 💬 1件: LPAR1 💬 8件: Gap junction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Regulation of actin cytoskeleton 💬1件: 85 💬
3BMS-986278Product Code: BMS-986278Pharmaceutical Form: Film-coated tabletINN or Proposed INN: LPA1Current Sponsor code: BMS-986278Other descriptive name: BMS-986278Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral useProduct Name: BMS-986278Product Code: BMS-986278Pharmaceutical Form: Film-coated tabletINN or Proposed INN: LPA1Current Sponsor code: BMS-986278Other descriptive name: BMS-986278Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 30-Pharmaceutical form of the placebo: Film-coated tabletRoute of administration of the placebo: Oral use----1件: 85 💬